Headlines about herbal supplements containing rice, wheat and houseplants rather than the herb on the label were, for a period, a regular feature of consumer journalism. They rested on DNA barcoding: sequencing a short stretch of genetic material from a product and matching it against a reference database to identify which species it came from.
The technique is genuine and powerful. Applied to raw plant material it can distinguish species that look identical once dried and ground, and it does so without any expertise in botanical morphology. Applied to a bottle of capsules containing a standardised extract, it can produce a result that is confidently and entirely wrong, because the manufacturing process that produced the extract also destroyed the DNA the test depends on.
This is not a small technical caveat. It is the central issue in interpreting any DNA-based finding about a supplement, and it explains why some widely publicised results were later disputed by scientists who had no interest in defending the supplement industry.
Key takeaways
- DNA barcoding identifies species by sequencing a short standardised region and matching it against reference sequences.
- Plants need several marker regions rather than one, because no single region separates all plant species reliably.
- Heat, solvents and pH during extraction fragment DNA, so a negative result on an extract may mean nothing was detectable rather than nothing was present.
- Substitution and filler findings are real, but the interpretation of some early studies was contested on methodological grounds.
- Chemical fingerprinting answers what a product contains; DNA answers what it was made from. Serious testing uses both.
How Barcoding Identifies Plant Material
The idea behind DNA barcoding is that a short, standardised region of the genome can act as a species identifier, much as a printed barcode identifies a product. The region must vary enough between species to distinguish them and vary little enough within a species that all members share it, and it must be flanked by sequences conserved enough that a single pair of primers can amplify it across a wide range of organisms.
The workflow has four steps. DNA is extracted from the sample, breaking open cells and separating nucleic acid from proteins, polysaccharides and the pigments and phenolics that plants carry in abundance. The marker region is amplified by the polymerase chain reaction, using primers that bind the conserved flanking sequences. The amplified product is sequenced. And the resulting sequence is compared against a reference database to find its closest match.
Each step has failure modes. Extraction from plants is harder than from animal tissue, because cell walls resist disruption and because the compounds that make herbs medicinally interesting inhibit the enzymes used downstream. Amplification needs template long enough to span the primer sites, which is where degraded material fails. Sequencing needs a reasonably pure product, so a mixture of species yields an unreadable overlapping trace. And database comparison can only return what has been deposited, so a species absent from the reference set matches whatever relative is present.
That last point deserves emphasis. A barcoding result is a statement about similarity to database entries, not an absolute identification. Reference databases contain misidentified entries deposited in good faith, and coverage of medicinal plants is uneven. A confident-looking match is only as good as the reference behind it.
Marker Regions Used for Plants

Animal barcoding settled quickly on a single region of the mitochondrial genome, and it works well across most animal groups. Plants have no equivalent, and the reason is biological rather than technical.
Plant mitochondrial genomes evolve slowly in their coding sequences and rearrange their structure readily, a combination that makes them poor barcodes. Attention therefore moved to the chloroplast genome and to nuclear ribosomal regions, and the outcome was not a single marker but a small set used in combination.
Two chloroplast genes form the usual core. One is a segment of the gene encoding the large subunit of the enzyme responsible for carbon fixation, which amplifies reliably across almost all plants but discriminates poorly between close relatives. The other encodes a maturase enzyme, which discriminates better but amplifies less consistently. Together they trade coverage against resolution.
Two further regions are widely added. A spacer between two chloroplast genes offers good discrimination in many groups, though it contains repeats that complicate sequencing. And the internal transcribed spacer of the nuclear ribosomal cluster, particularly its second segment, has become the most used single marker for medicinal plants specifically. It is short, present in very many copies per cell, and variable enough to separate many species that the chloroplast markers cannot.
The high copy number matters more than it might appear. A degraded sample contains few intact stretches of any given sequence, and a region present in hundreds or thousands of copies per cell has a far better chance of yielding one amplifiable fragment than a single-copy region does. Short markers also survive fragmentation better than long ones, which is why mini-barcodes of a hundred or so bases have become the practical choice for processed material.
| Marker region | Genome | Main strength | Main limitation |
|---|---|---|---|
| Large subunit gene segment | Chloroplast | Amplifies across nearly all plants | Poor at separating close relatives |
| Maturase gene | Chloroplast | Better species discrimination | Less reliable amplification |
| Intergenic spacer | Chloroplast | Good resolution in many groups | Repeat regions complicate sequencing |
| Internal transcribed spacer | Nuclear ribosomal | High copy number, good resolution | Multiple variants within one plant |
| Mini-barcodes | Various | Works on fragmented DNA | Less discriminating, needs good reference data |
Even with the full set, some genera remain difficult. Recently diverged species, hybrids, and groups that reproduce without sexual recombination can share barcode sequences despite differing substantially in chemistry, which matters when one is medicinal and another is not.
Why Extracts Defeat DNA Methods
This is the pitfall that turns a valid method into a misleading one, and it follows from what DNA is and what manufacturing does to it.
DNA is a long polymer held together by phosphodiester bonds, and those bonds are broken by heat, by acid, and by prolonged exposure to certain solvents. Enzymes released when plant tissue is damaged also degrade it. Every one of these conditions occurs during the production of a herbal extract.
Consider what happens to a root that becomes a capsule of standardised extract. It is dried, often with heat. It is milled. It is macerated or percolated with a solvent, commonly ethanol and water, sometimes at elevated temperature, for hours. The liquid is separated from the plant solids, which are discarded, and the liquid is concentrated by evaporation, again with heat. The concentrate may be spray-dried onto a carrier, which involves brief exposure to a hot gas stream. The powder is blended with excipients and encapsulated.
Two things have happened. The DNA that survived the process has been fragmented into pieces too short to span primer binding sites. And, more fundamentally, the solid plant material in which most of the DNA resided was filtered out and thrown away, since the point of an extract is to carry compounds that dissolve in the solvent, and DNA largely does not partition into an ethanolic extract in useful quantity.
So a DNA test on a genuine, high-quality extract of the correct species will frequently return no amplifiable plant DNA at all, or will return DNA from whatever excipient was added rather than from the herb. Rice flour, maltodextrin and cellulose are common carriers, and they carry their own intact genomes.
This makes negative and unexpected results ambiguous in a specific way. Finding rice DNA in an extract capsule may mean the product was adulterated with rice flour as a cheap filler. It may equally mean rice starch was used as a declared carrier and its DNA survived while the herb’s did not. Distinguishing these requires knowing the formulation, and a laboratory testing a retail product blind does not.
The gradient of testability runs roughly from whole dried herb, where DNA is abundant and intact, through cut and sifted material and simple milled powders where it is usually recoverable, to concentrated and standardised extracts where it is often absent, to purified single-compound preparations where the question is meaningless.
Filler and Substitute Species Findings
None of the above means substitution is imaginary. Botanical adulteration is a genuine and long-standing problem with several distinct forms, and DNA methods have contributed real evidence about it.
Substitution occurs when a different species is supplied in place of the labelled one. Sometimes it is deliberate fraud, exploiting the fact that dried powdered material of one species looks identical to another. Sometimes it reflects genuine confusion, since common names are shared between unrelated plants and regional pharmacopoeias assign the same name to different species. Sometimes it happens at harvest, when collectors of wild material take a look-alike growing alongside the target.
Dilution with inert filler is a separate practice, in which cheap bulk material extends an expensive herb. Contamination is different again, involving unintended material from shared equipment, storage or the field.
The consequences vary from none to serious. A capsule diluted with rice powder underdelivers but rarely harms. A substituted species may be pharmacologically inert, or may carry compounds with real toxicity, and there have been well-documented episodes in which a toxic species substituted for an intended one caused significant injury to numbers of people. This is why identity testing is not a purely commercial concern.
DNA methods are particularly good at detecting these problems in raw material, which is where they belong in a quality system. A supplier delivering dried root can be checked before it enters production, when the material is at its most testable and when rejecting a batch is still straightforward. Testing the finished capsule is testing at the point where the method works worst and where remediation is most expensive.
Criticism of Early Barcoding Studies
Several high-profile investigations reported that a large fraction of tested herbal products did not contain the labelled species, and the results were widely reported. Scientists working in botanical authentication raised substantial objections, and the objections were technical rather than defensive.
The central criticism was the one described above: applying DNA methods to extracts and interpreting the absence of a detectable barcode as absence of the herb. A product can contain the correct botanical, at the correct concentration, with the correct chemistry, and yield no amplifiable DNA. Reporting that as failure to detect the species is defensible; reporting it as evidence the product does not contain the species is not.
Related objections followed. Some studies used a single marker region rather than a set, which reduces the chance of amplification and the reliability of identification. Some drew conclusions from database matches without confirming them by other means. Some did not report positive and negative controls in a way that let readers judge whether extraction and amplification had worked at all, which is essential when a negative result is the finding. And some did not distinguish between DNA from a declared excipient and DNA from an undeclared adulterant.
The methodological response has been constructive. Consensus has grown around several principles: use multiple markers, use mini-barcodes for processed material, run controls that demonstrate the method could have detected the target had it been present, characterise the product form before choosing a method, and treat DNA evidence as one input alongside chemical analysis rather than as a verdict.
The reasonable conclusion is neither that the early studies were worthless nor that their headline figures should be repeated. They drew attention to a real problem and they overstated it in a specific and identifiable way. Later work using appropriate methods has continued to find substitution and adulteration, generally at lower rates than the most alarming reports, and concentrated in particular product categories and supply chains rather than spread evenly across the market.
Chemical Fingerprinting as a Complement
DNA and chemistry answer different questions, and the difference is the key to using either sensibly. DNA tells you what organism the material came from. Chemistry tells you what compounds are present now. A product can pass one and fail the other in both directions.
The chemical toolkit has several layers. Thin layer chromatography separates an extract on a coated plate and produces a pattern of spots compared against a reference; it is cheap, quick, surprisingly discriminating, and still a workhorse in pharmacopoeial monographs. High performance liquid chromatography resolves compounds far better and quantifies markers against standards, which is how a standardised extract’s claimed content is verified. Mass spectrometry coupled to chromatography identifies compounds by mass and fragmentation, catching species-specific markers and undeclared additions. Infrared spectroscopy compares whole spectra against reference libraries fast enough for use at goods-in.
Each has limits. Marker compounds are frequently shared between related species, so chemistry alone may not distinguish a genuine article from a close relative. Chemical profiles vary with growing conditions, harvest time, plant part and processing, so a legitimate batch can look unusual. And measuring one marker compound says nothing about the rest of the extract, which is why adding a purified compound to a weak extract is a known form of adulteration that a single-marker assay will not catch.
Microscopy deserves mention alongside these. For powdered raw material, examining cell structures, starch grains, trichomes and crystals under a microscope remains a valid pharmacopoeial identity method, cheap and requiring no instrumentation beyond the microscope, though it requires an experienced analyst.
The sensible arrangement uses each where it is strongest: DNA or microscopy on incoming raw material to confirm botanical identity, chemistry through processing and on the finished product to confirm composition and concentration, and heavy metal, pesticide and microbiological testing alongside both.
Choosing the Right Test for the Product Form
The practical question for anyone reading a test report, or deciding what testing to ask for, is whether the method suits the material.
For whole or cut dried herb, DNA barcoding is well suited and so is microscopy. Material is unprocessed, DNA is intact, and identity is the main question. For a milled powder of the whole plant part, DNA usually still works, though the extraction step becomes harder as surface area and exposure increase. For a simple encapsulated powder, the same applies, with the caveat that excipients contribute their own DNA.
For a concentrated or standardised extract, DNA is the wrong primary tool. Chemistry is the appropriate method, verifying both the fingerprint of the whole extract and the concentration of marker compounds. Where botanical identity of the source material matters, the place to establish it is upstream, at the raw material stage, and a manufacturer with a proper quality system will have done so and will be able to say so.
For tinctures and liquid preparations, chemistry again. For a purified isolated compound, identity of the compound is the only meaningful question and both botanical methods are irrelevant.
For a consumer, the actionable version is short. A certificate of analysis is more informative than a testing logo, and the questions worth asking of one are which tests were run, on which batch, and by whom. Independent third-party verification programmes exist and generally test finished products against their labels using chemical methods. And a product whose marketing leans on DNA verification of an extract is making a claim that deserves a question rather than confidence.
Frequently asked questions
If DNA testing does not work on extracts, how do I know my extract is genuine?
Through the manufacturer’s quality system and through chemical analysis of the finished product. A serious producer identifies raw material on arrival, when DNA and microscopy work well, keeps records tying each batch of finished product to identified starting material, and verifies the finished extract chemically against a reference fingerprint and marker compound specification. As a purchaser, what you can look for is a certificate of analysis for your specific batch, participation in a recognised third-party verification programme, and a company that answers questions about where its raw material comes from.
Does a DNA test finding rice mean my supplement was adulterated?
Not necessarily, and this ambiguity is one of the main criticisms of testing finished products blind. Rice flour and rice starch are common, legitimate, declared excipients used as carriers and flow agents, and their DNA survives processing that destroys the herb’s DNA. So rice DNA may be the signature of an honest formulation whose herbal component happens to be undetectable. It may also be undeclared bulking. The label’s ingredient list is the first place to check, and a discrepancy between what the label declares and what is found is the finding that matters.
Is DNA barcoding able to tell how much of a herb is present?
Not in its standard form. Conventional barcoding is a presence or absence method: it amplifies whatever template it can find and identifies it. The amount of DNA recovered depends on processing history far more than on how much plant material went in, so a strong signal does not mean a high dose. Quantitative approaches based on real-time amplification exist and can estimate relative amounts under controlled conditions, but they still measure DNA rather than active compounds, and the relationship between the two is not fixed.
Are there plants that DNA barcoding cannot distinguish?
Yes, and this is a genuine limitation rather than an execution problem. Species that diverged recently may share identical sequences at the standard marker regions despite differing in chemistry. Hybrids carry sequences from both parents. Some groups reproduce clonally in ways that blur species boundaries. And where a medicinal species and a closely related non-medicinal one differ only in compounds rather than in the barcode regions, DNA cannot separate them and chemistry must. Reference database gaps compound this, since a species with no deposited sequence will match to a relative.
Should I avoid herbal supplements because of adulteration reports?
That is a personal judgement, but the evidence supports being selective rather than avoidant. Problems are real and are concentrated in particular categories: expensive botanicals with cheap look-alikes, products from opaque supply chains, and anything sold with claims that would command a premium. They are far less common in products from manufacturers with documented quality systems and independent verification. The more consequential risks with herbal products for many people are interactions with prescribed medicines and contamination with heavy metals or undeclared pharmaceuticals, both of which are worth raising with a clinician or pharmacist.
The useful mental model is that a supplement has a history, and different tests read different parts of it. DNA reads the beginning, telling you what was harvested. Chemistry reads the end, telling you what is in the capsule now. Manufacturing sits between them, and it is precisely the step that erases the first record while creating the second. Any testing claim that ignores which part of the history it is reading should be treated with the same caution as a label claim it was meant to verify.
This is education, not medical advice. Laboratory results only carry meaning alongside your symptoms, history and examination. Talk to a qualified clinician about your own results before changing anything about your care or supplements.




